Department of SICU, Research Institute of General Surgery , Jinling Hospital
Nanjing, Jiangsu, China
NCT Number: NCT01507766
As an important management of severe acute pancreatitis (SAP), enteral nutrition (EN), especially early enteral nutrition (EEN) increases the blood flow of gut mucosa and stimulates the intestinal motility. Moreover, EEN maintains the gut integrity, prevents bacterial and endotoxin translocation and thereby theoretically reduces the incidence of infections. Therefore, EEN has the ability to reduce the infectious complications, length of hospital stay and mortality of patients with SAP.
However, the role of EEN is considered to be influenced by intra-abdominal hypertension (IAH) in patients with SAP. The previous studies showed that gut was the most sensitive splanchnic organ to the increase of intra-abdominal pressure (IAP). When IAH occurs, it reduces the blood flow of gut, and then results in the development of intestinal ischemia and edema. The hypoxia and hypoperfusion of intestine leads to the increase of permeability of the intestinal mucosal barrier, and then leads to bacterial translocation. Therefore, IAH could result in the gastrointestinal dysfunction. Nevertheless, the different impacts of specific IAP values on the tolerance of EEN have not been reported.
Furthermore, the effects of early enteral feeding on the IAP in SAP also remain unknown. Due to the severe inflammatory response of SAP, could EEN increase the burden of bowel, cause expansion of intestinal cavity, thus increase IAP? However, there were rare literatures up to date reporting the association between EEN and IAH in patients with SAP. Therefore, the present study aimed to investigate the influence of specific IAP on the tolerance of early enteral feeding, as well as the effects of EEN on IAP in SAP patients. Moreover, the impacts of EEN on the disease severity and clinical outcome of SAP were also researched.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 4
Nanjing, Jiangsu, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The enteral nutrition was started within 48h after admission
The enteral nutrition was started at the 8th day after admission
Time frame: 14 days
The caloric intake and tolerance of feeding were recorded daily after enteral nutrition was started
Time frame: 14 days
The value of intra-abdominal pressure (per 6 hours) and the incidence of intra-abdominal hypertension
Time frame: 14 days
Hospital mortality; Duration of ICU stay; The development of multiple organ dysfunction syndrome and pancreatic infection; APACHEII score; SOFA score; CRP levels
Time frame: 14 days
IgA, IgG, IgM, CD4+/CD8+T cell and HLA-DR
Nanjing University School of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04525027
Acute Pancreatitis, Cardiovascular Diseases
New Delhi, National Capital Territory of Delhi, India
View Trial DetailsNCT02543658
Acute Pancreatitis, Cardiovascular Diseases
Nanchang, Jiangxi, China
View Trial DetailsNCT07712081
Acute Pancreatitis, Digestive System Diseases
Rui’an, Zhejiang, China
View Trial DetailsNCT05651360
Abdominal Pain, Acute Appendicitis
Odense, Denmark
View Trial Details